Surgery, Gastroenterology and Oncology
Vol. 23, Nr. 5, Oct 2018
Long-term Outcome of Adjuvant Chemotherapy with S-1 Consisting of 3-week Administration Followed by 1-week Rest for Stage III Colorectal Cancer
Hidejiro Kawahara, Yuki Hiramoto, Mitsumasa Takeda, Tomo Matusmoto, Takeyuki Misawa, Katsuhiko Yanaga
ORIGINAL PAPER, Oct 2018
Article DOI: 10.21614/sgo-23-5-330
Background Aims: The aim of this study is to evaluate long-term outcome of 3-week method (3-week administration followed by 1-week rest) for colorectal cancer as adjuvant chemotherapy with an oral anticancer drug, S-1.

Methods: Between 2008 and 2012, 142 patients with stage III colorectal cancer who underwent curative resection in our hospital and received oral adjuvant chemotherapy with S-1 for six months were enrolled in this study.
They were divided into two groups, 3-week method or 4-week method (4-week administration followed 2-week rest).

Results: The six-month completion rate in the 3-week method group was 100% (49 49) which was significantly better than that in the 4-week method group, 85% (79 93) (p=0.002). In total patients, five-year relapse-free survival rates in the 3-week method group was 89.6% which was significantly better than that in the 4-week method group, 74.2% (p=0.027).
There were no grade 3 or 4 adverse reactions in both laboratory and clinical findings in the 3-week method group.

Conclusions: The 3-week method of S-1 administration had good feasibility, high accumulated dose in six months and good relapse-free survival rates. The 3-week method with S-1 seems to be a standard adjuvant chemotherapy schedule for colorectal cancer.

Full Text Sources: Download pdf
Abstract:   Abstract EN


Journal Subscriptions

Current Issue

Oct 2018

Supplements

Instructions for authors
Online submission
Contact
Print ISSN: 2559 - 723X

ISSN-L: 2559 - 723X

ISSN online: 2601 - 1700

Surgery, Gastroenterology and Oncology is indexed in Scopus, CrossRef (DOI: 10.21614/sgo)



Meetings and Courses in 2018